Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2021 | Improving support services for patients with R/R DLBCL

Mallory Yung • 12 Dec 2021
ASH 2021
Diffuse Large B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma

Mallory Yung, MPH, Avalere Health, Washington, DC, shares her insights on how the results from an analysis on shared treatment decision-making in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) suggest that there is a major educational gap for patients and caregivers in this setting. Ms Yung highlights that it is important to use these findings to offer better educational material and support services for patients and caregivers when treating R/R DLBCL. This interview took place at the 63rd ASH Annual Meeting and Exposition congress, Atlanta, 2021.

Disclosures

Funding by Morphosys

More from Mallory Yung

3:12
An analysis of shared treatment decision-making in patients with R/R DLBCL
Mallory Yung • 12 Dec 2021

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals